{"filings":[{"id":150657,"accession_number":"0001213900-25-042645","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Hongchang International changes fiscal year end from Dec 31 to March 31","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board approved change on May 12, 2025, effective immediately.","New fiscal year ends March 31, replacing prior December 31 year-end.","Transition report on Form 10-K will cover Jan 1, 2025 to March 31, 2025.","First full fiscal year under new calendar will end March 31, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150656,"accession_number":"0001213900-25-037594","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["4.01","5.02","9.01"],"status":"ready","headline":"Hongchang International replaces auditor WWC with Enrome; Chairman Ban Siong Ang steps down; Board Secretary resigns","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed WWC, P.C. as independent auditor; appointed Enrome LLP for FY ending Dec 31, 2025, effective Apr 24, 2025.","No disagreements or reportable events with WWC during 2023 and 2024 fiscal years.","Ban Siong Ang resigned as Chairman of the Board (remains as director), effective Apr 24, 2025.","Zengqiang Lin, CEO/CFO/President/director, appointed as Chairman, effective Apr 24, 2025.","Qingqing Wang resigned as Board Secretary, effective Apr 24, 2025; not due to any dispute or disagreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203232,"accession_number":"0001213900-24-073061","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K/A","filed_at":"2024-08-28T23:59:59+00:00","items":["5.06"],"status":"ready","headline":"Hongchang International ceases shell company status, filing amendment clarifies","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Filed Amendment No. 1 to 8-K dated Sep 7, 2023 to clarify cessation of shell company status.","Company states it ceased being a shell company as defined in Rule 12b-2 of the Exchange Act.","No specific business combination or operational details provided in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219559,"accession_number":"0001213900-24-040865","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2024-05-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Hongchang International CFO Wendy Li and Director Xingjia Gao resign; CEO takes CFO role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Wendy Li resigned May 8, 2024, for personal reasons; no disagreement with operations, policies, or practices.","Director Xingjia Gao also resigned May 8, 2024, for personal reasons, unrelated to any disagreements.","CEO and Director Zengqiang Lin appointed as CFO effective May 8, 2024, adding to his existing roles."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219558,"accession_number":"0001213900-24-028741","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2024-04-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Hongchang International director resigns; appoints new board secretary","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stephan Truly Busch resigned as director effective March 27, 2024; resignation unrelated to any policy disagreements.","Qingqing Wang appointed Board Secretary effective same date; she joined the company as financial manager in November 2022.","Wang holds a bachelor's in financial management from Minnan Normal University and an intermediate accountant certificate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256903,"accession_number":"0001213900-23-090566","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2023-11-28T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Hongchang International completes name change; OTC ticker now HCIL","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name changed from Heyu Biological Technology Corporation to Hongchang International Co., Ltd, effective November 28, 2023.","Ticker symbol on OTC Markets changed from HYBT to HCIL, effective November 28, 2023.","Certificate of Amendment to Articles of Incorporation filed with Nevada Secretary of State."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256902,"accession_number":"0001213900-23-089900","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2023-11-24T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Hongchang International adopts amended bylaws effective Nov 23, 2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved and adopted amended and restated bylaws on Nov 23, 2023.","Corporate powers must be exercised by board as a whole unless resolved otherwise.","Directors may only exercise powers via board resolution or written consent.","President (if also a director) presides at shareholder and board meetings absent chairman."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256901,"accession_number":"0001213900-23-089247","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2023-11-21T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Heyu Biological Technology renamed to Hongchang International Co., Ltd effective Nov 17","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name change approved by board Oct 6, 2023 and controlling shareholder (68.1% ownership) on Nov 17, 2023.","Company will apply for a new stock symbol with FINRA; previous symbol not listed.","Certificate of Amendment filed with Nevada Secretary of State on Nov 17, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274239,"accession_number":"0001213900-23-074978","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2023-09-07T23:59:59+00:00","items":["1.01","2.01","3.02","5.01","5.02","9.01"],"status":"ready","headline":"Heyu Biological Technology acquires Hongchang Group in reverse merger, exits prior cancer therapy business","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired all shares of Hongchang BVI for 415.6M new shares (80.1% of post-acquisition total).","Disposed of prior business (HP TECHNOLOGY, Jiashierle, Kangzi) to director Ban Siong Ang for nominal consideration.","New business: Hongchang Food Industrial Park (under construction, completion expected 2024) in Fujian, China.","Mr. Zengqiang Lin becomes controlling shareholder via Zengqiang Investment Limited (415.6M shares).","Company now has 518.8M shares outstanding; new executive offices in Fuqing City, Fujian, China."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274238,"accession_number":"0001213900-23-070271","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2023-08-23T23:59:59+00:00","items":["1.01","3.02","5.01","5.02","2.01","9.01"],"status":"ready","headline":"Heyu Biological to acquire Hongchang BVI in reverse merger; 80.1% control to sellers","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Issues 415,582,375 shares (80.1% of post-close total) to acquire Hongchang BVI, which owns Fujian food industrial park.","Existing business (HP TECHNOLOGY LIMITED and subsidiaries) sold to director Ban Siong Ang for nominal consideration.","Board and management overhaul: CEO, CFO, and three directors resign; Zengqiang Lin appointed CEO/President; Wendy Li CFO.","New directors include Zengqiang Lin, Zhenzhu Lin, Stephan Truly Busch, and Xingjia Gao; Ban Siong Ang remains Chairman.","Transactions closed August 21, 2023; shares issued under Regulation S exemption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274237,"accession_number":"0001213900-23-067114","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2023-08-14T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Heyu Biological Technology effects 1-for-10 reverse stock split","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["One-for-ten reverse stock split effective August 8, 2023. Share count reduced by ratio of 1:10.","No fractional shares issued; fractional interests rounded up to nearest whole share.","Certificate of Amendment filed with Nevada Secretary of State. Outstanding shares reduced proportionally."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312249,"accession_number":"0001213900-23-013396","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2023-02-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Heyu Biological appoints Zengqiang Lin as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Mr. Zengqiang Lin as independent director effective February 17, 2023.","Lin is founder and chairman of Fuqing Hongchang Food Co., Ltd (biotechnology-led food trading) since 2017.","Previously general manager of Fujian Yuweixiang Frozen Food Co., Ltd (June 2016 - Dec 2017) and manager at Xizang Changhui Construction Engineering (July 2015 - May 2016).","Lin graduated from Fuzhou Foreign Trade College."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":384604,"accession_number":"0001213900-22-000837","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2022-01-06T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Heyu Bio receives SEC non-compliance letter; faces potential registration revocation","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received SEC letter dated Dec 17, 2021 (received Dec 30) citing non-compliance with Section 13(a) reporting.","SEC warned of possible administrative proceeding to revoke registration or trading suspension if filings not made within 15 days.","Company responded Jan 1, 2022 requesting extension; preparing filings with auditor WWC, P.C. and outside counsel."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":402482,"accession_number":"0001213900-21-062445","cik":1086303,"company_name":"Hongchang International Co., Ltd","ticker":"HCIL","form_type":"8-K","filed_at":"2021-11-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Heyu Biological appoints Bo Lyu as CFO effective Nov. 30, 2021","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mr. Bo Lyu appointed Chief Financial Officer effective November 30, 2021.","Previously served as financial controller of Building Dreamstar Technology Inc. (Aug 2020-Oct 2021).","Earlier roles include board secretary at Dragon Victory International (LYL) and Hailiang Education (HLG).","Holds bachelor's from Wuhan University, master's in Finance from Albert-Ludwigs-Universität Freiburg, and is a CFA II candidate."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":64853920.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}